Evidence map›Paper›PMID 37438135›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Cardiac Tamponade as an Initial Manifestation of Diffuse Large B-cell Lymphoma One Year after IgG4-related Disease in Remission.

Soichiro Yamaji, Kenjiro Kamezaki, Maroka Shinchi, Katsumi Takizawa, Chie Abe, Akihiro Koike, Mika Kuroiwa

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Soichiro YamajiDepartment of Hematology, National Hospital Organization Fukuokahigashi Medical Center, Japan.
Kenjiro KamezakiDepartment of Hematology, National Hospital Organization Fukuokahigashi Medical Center, Japan.
Maroka ShinchiDepartment of Cardiology, National Hospital Organization Fukuokahigashi Medical Center, Japan.
Katsumi TakizawaDepartment of Pathology, National Hospital Organization Fukuokahigashi Medical Center, Japan.
Chie AbeDepartment of Pathology, National Hospital Organization Fukuokahigashi Medical Center, Japan.
Akihiro KoikeDepartment of Cardiology, National Hospital Organization Fukuokahigashi Medical Center, Japan.
Mika KuroiwaDepartment of Hematology, National Hospital Organization Fukuokahigashi Medical Center, Japan.
Fukuoka Higashi Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 65-year-old man with multiple lymphadenopathies was diagnosed with IgG4-related disease (IgG4-RD) based on findings of a cervical lymph node biopsy and an elevated serum IgG4 level. Treatment was initiated after the onset of autoimmune pancreatitis, and he achieved remission. He developed diffuse large B-cell lymphoma one year later. Pericardial involvement of lymphoma resulted in cardiac tamponade, and he died before histopathological confirmation of lymphoma was made due to a lethal arrhythmia caused by massive involvement of lymphoma into the myocardium. Because patients with IgG4-RD might have an increased risk of malignant diseases, including lymphoma, histopathological examinations should be considered at any time during the course of IgG4-RD.

Indexed as

Autoimmune PancreatitisCardiac TamponadeImmunoglobulin G4-Related DiseaseLymphadenopathyLymphoma, Large B-Cell, DiffuseAgedHumansMalecardiac tamponadediffuse large B-cell lymphomaIgG4-related disease

Identifiers

PMID37438135
PMCPMC10982006
OpenAlexW4383900293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.